News

Sarepta Therapeutics laying off dozens in Ohio, won't comply with FDA request to halt therapy
After the FDA request, Cambridge, Massachusetts-based Sarepta said in a statement that it will continue to ship the therapy to ambulatory people but maintain a halt it implemented June 15 for ...
STAT4h
FDA taps biotech veteran George Tidmarsh to lead drug center
The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in ...
Fierce Pharma5h
Sarepta stands behind Elevidys after FDA requests gene therapy be pulled from market
As the controversy over the safety of Sarepta Therapeutics’ gene therapies comes to a head, the biotech is standing firm ...
Cambridge pharma company lays off almost 500 amid FDA dispute over treatment
A Massachusetts biotechnology company is laying off nearly 500 employees, more than a third of its total workforce, as it faces pushback from the U.S. Food and Drug Administration on one of its ...
FDA names former pharmaceutical company executive to oversee US drug program
FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...
Renal & Urology News6h
Thousands Laid off From NIH, FDA and CDC After Supreme Court Decision
The layoffs followed a March announcement by Health Secretary Robert F. Kennedy Jr., who called for a major department overhaul.
KFF Health News6h
NIH, FDA Cuts Would Lead To Fewer New Meds, CBO Analysis Indicates
An estimated 53 drugs would not enter the market in the next 30 years if the NIH is hit with a permanent 10% budget cut and the FDA experiences a nine-month drug review delay due to staffing cuts, the ...